NINDS Neuroscience Funding Announcements

Withdrawal of NINDS Participation in PAR-10-001, "Drug Discovery for Nervous System Disorders (R01)"

Funding Contact(s): Rebecca  Farkas, Ph.D.
Funding Categories: Translational Research

Brief Description:
This Notice informs potential applicants that, effective immediately, the National Institute of Neurological Disorders and Stroke (NINDS) will no longer accept applications under PAR-10-001, "Drug Discovery for Nervous System Disorders (R01)," beginning with the February 5, 2012 receipt date. Researchers seeking support for chemical optimization of small molecules probes for preclinical, in vivo proof-of-concept experiments for the purposes of drug discovery should consider PAR-12-060, "Solicitation of Validated Hits for the Discovery of in vivo Chemical Probes (R01)."

NIH Guide: NOT-NS-12-008
Release Date: 2011-12-21
Expiration Date: 2013-01-08